Medical/Pharmaceuticals

Scripps Research Institute testing shows Viraleze highly active against UK COVID strain

MELBOURNE, Australia, June 1, 2021 /PRNewswire/ -- Australia's Viraleze anti-COVID nasal spray is active against the highly infectious UK variant of SARS-CoV-2, the virus that causes COVID-19, reducing infectivity of the virus by >98%, it was announced today in a major development for the product...

2021-06-01 17:30 2178

Australia's original prolonged-release melatonin now available over the counter at pharmacies

MAIN POINTS * Circadin® prolonged-release melatonin is now available without prescription1 * Circadin® is clinically proven in people aged 55 and over2 to help them fall asleep quicker, sleep better, wake refreshed, and in turn improve quality of life3 * Circadin® mimics the effect of the b...

2021-06-01 17:05 2370

Amgen and Kyowa Kirin to Jointly Develop and Commercialize KHK4083, a Phase 3-Ready, Potential First-In-Class Treatment for Atopic Dermatitis

Agreement Renews Successful Global Collaboration That led to Several Groundbreaking Therapies in Multiple Disease Areas KHK4083 Depletes OX40-Expressing T cells Associated with Atopic Dermatitis and Several Other Inflammatory Diseases Moderate-to-Severe Atopic Dermatitis Affects Nearly 30 Mill...

2021-06-01 16:00 5598

100th Elekta Unity MR-Linac goes to St George's Hospital in New Zealand

CHRISTCHURCH, New Zealand, June 1, 2021 /PRNewswire/ -- Elekta (EKTA-B.ST) announces that St George's Hospital inChristchurch, New Zealand, has ordered an Elekta Unity MR-Linac, making it the 100th device sold since introduction. Today, the innovative radiation therapy device is found in 14 count...

2021-06-01 15:07 5288

AVATAMED sets up Joint Service Lab with A*STAR's Institute of Molecular and Cell Biology to offer Precision Oncology Services

SINGAPORE, June 1, 2021 /PRNewswire/ -- AVATAMED (www.avatamed.com ), a precision medicine service company based in Singapore, announced the setting up of a joint lab with Singapore's Institute of Molecular and Cell Biology (IMCB) at the Agency for Science, Technology an...

2021-06-01 09:00 2821

Innovent Biologics and AnHeart Therapeutics Jointly Announce Exclusive License Agreement for Taletrectinib in Greater China

SAN FRANCISCO and SUZHOU, China, June 1, 2021 /PRNewswire/ -- Innovent Biologics, Inc. (Innovent) (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of cancer, metabolic, autoimmune and other major disease...

2021-06-01 08:00 5341

Introduce the World's First Biomedical Application Mask that Revolutionizes Face Mask to Resist Aerosol Transmission

TAIPEI, May 31, 2021 /PRNewswire/ -- Taer Innovation has won design awards including Good Design award from 2012 to 2014 Golden Pin Design award, Taiwan Excellence award in 2014 and Computex d&I award in 2014 for their products.The companyfocuses on medical innovation and technology. The company'...

2021-05-31 23:00 2362

PENTAX Medical and Vedkang Establish Endoscopic Therapeutics Joint Venture

TOKYO, May 31, 2021 /PRNewswire/ -- PENTAX Medical (a division of HOYA Group) and Jiangsu Vedkang Medical Science and Technology Co., Ltd (Vedkang) today announced the establishment of a joint venture- PENTAX Medical Therapeutics ( Jiangsu) Co., Ltd.(*) to develop single-use therapeutics products ...

2021-05-31 21:00 3039

PolyU develops biomimetic nanosheet for cancer therapy and imaging

HONG KONG, May 31, 2021 /PRNewswire/ -- A research team from the Department of Applied Biology and Chemical Technology (ABCT) of The Hong Kong Polytechnic University (PolyU) has developed a novel type of biomimetic nanosheet with a multi-modal imaging function, which can track tumour development ...

2021-05-31 19:42 3139

RhoVac Confirms Forecast - BRaVac Phase IIb study recruitment to close in Quarter 3 2021

STOCKHOLM, May 31, 2021 /PRNewswire/ -- RhoVac AB ("RhoVac"), a Swedish cancer immunotherapy company, announces today,May 31, 2021, that it confirms its previous forecast to be able to conclude recruitment for its multi-centre BRaVac Phase IIb study in Quarter 3 2021. Also, all new US clinics hav...

2021-05-31 19:33 2214

Samsung Biologics to add mRNA vaccine drug substance manufacturing suite to expand portfolio of services

* Samsung Biologics, a global leading CDMO, will add mRNA vaccine DS production capability to its existing facility by the first half of 2022 * The addition will enable Samsung Biologics to provide end-to-end mRNA vaccine manufacturing services from bulk drug substance to aseptic fill/finish ...

2021-05-31 19:00 3115

Moleac Announces US FDA Approval of IND Application for Phase 1 Study of MLC1501 Programme in Post-Traumatic Brain Injury Recovery

SINGAPORE, May 31, 2021 /PRNewswire/ -- Moleac, a biopharmaceutical company based inSingapore, announced the approval by the U.S. Food and Drug Administration (FDA) of an investigational new drug (IND) application for MLC1501 in traumatic brain injury (TBI). Moleac is dedicated in finding, devel...

2021-05-31 18:33 3041

Mindray Defines Future of Imaging Technologies with New General Imaging, Women's Healthcare and Cardiology Ultrasound Solutions

SHENZHEN, China, May 31, 2021 /PRNewswire/ -- Mindray (SZSE: 300760), a global leading developer and provider of medical devices and solutions, has announced the launch of its new General Imaging, Women's Healthcare, and Cardiology ultrasound solutions onMay 28, 2021. Underpinned by the theme "In...

2021-05-31 10:15 8852

Hummingbird Bioscience Announces Publication of Abstract on Anti-VISTA Antibody HMBD-002 at the American Society of Clinical Oncology (ASCO) 2021 Annual Meeting

* HMBD-002 is the only IgG4 isotype anti-VISTA antibody currently in development * HMBD-002 is anticipated to enter a Phase 1 clinical trial in 2021 HOUSTON andSINGAPORE, May 31, 2021 /PRNewswire/ -- Hummingbird Bioscience, an innovative clinical-stage biotech company focused on developing pr...

2021-05-31 10:00 2340

An Taiwanese Hearing-impaired Actor, Easton Dong Calls Out the "Listen Love" Project, to Raise Concerns for Hearing-impaired Students during the Covid-19 Pandemic.

TAIPEI, May 31, 2021 /PRNewswire/ -- The "Listen Love" donation project, led by Easton Dong, a hearing-impaired actor inTaiwan, and co-sponsored by TaerInno, aims to bring transparent masks to hearing-impaired students. Mr. Dong advocates this campaign to bring people awareness of difficulties en...

2021-05-31 08:00 2707

Nexturn Bio Inc. acquired a 50% stake in RosVivo Therapeutics, Inc.

SEOUL, South Korea, May 30, 2021 /PRNewswire/ -- Nexturn Bio Inc., a subsidiary of Nexturn Bioscience Co., Ltd., announced onMay 26th that it had acquired a 50% stake in RosVivo Therapeutics Inc. ("Rosvivo"), an American new drug developer, for about5.5 million U.S. dollars. As a result, Nexturn...

2021-05-30 22:00 5350

Dr. Seungpil Yu will hold a retirement ceremony and conclude his 46-year term as a pharmaceutical executive.

SEOUL, South Korea, May 28, 2021 /PRNewswire/ -- Dr. Seungpil Yu is a living witness to the long history of Yuyu Pharma, which celebrated its 80th anniversary this year, having laid the foundation for Yuyu Pharma to continue to thrive well into its 100th year. While in the United States, Dr. Yu r...

2021-05-28 21:00 3912

Revolutionary X-ray Technology From Australia to Transform American Airport Security

SeaTac chosen for Micro-X Inc's USA headquarters Official Opening at 10 am PDT, Friday May 28 855 S 192nd Street, Suite B600, Seattle, WA 98148 With: * Congressman Adam Smith, chair of the House Armed Services Committee * Brigadier Hugh Meggitt representing Australian Defence Staff, Embassy o...

2021-05-28 21:00 3572

Samsung Biologics Adds Four Global ISO Certifications For BCMS, Energy, Health & Safety, and Environmental Management

* Expanding upon its existing ISO22301 certification, Samsung Biologics is now fully certified with Business Continuity Management System for Security and Resilience across all business areas * Samsung Biologics adds ISO50001, ISO45001, ISO14001 for Energy Management, Occupational Health and ...

2021-05-28 20:00 3563

Year-end report, May-April 2020/21

Accelerated order growth STOCKHOLM, May 28, 2021 /PRNewswire/ -- During Elekta's fourth quarter, we drove strong order growth in all regions – both from market growth and market share gain – and we received our 100th Unity order. Installation volumes were similar to levels in the fourth quarter ...

2021-05-28 14:24 13678

Week's Top Stories